“This meeting started in 2015 and has achieved big success with more than 400 attendees including both basic researchers and clinicians specialized in HIV/AIDS. The purpose is to discuss the most relevant publications (basic science, clinical science and epidemiology/ public health) with one of the co-authors of the publications.”
“Barouch told MD Magazine the push for an HIV vaccine has been gaining momentum.
“We developed a consortium to advance this vaccine over the past several years,” he said. “We are very pleased that multiple funders, stakeholders, and collaborators have been very enthusiastic to work together to move this vaccine forward.”
At the one-year mark, the DNA vaccine was no longer effective, reports professor of medicine Dan Barouch, director of Harvard Medical School’s Center for Virology and Vaccine Research (CVVR) at […]
Healthy adults mounted strong immune responses after receiving an investigational whole inactivated Zika virus vaccine, according to interim analyses of three Phase 1, placebo-controlled, double-blind trials conducted at Beth Israel […]
Public-Private Partnership Begins Clinical Trial in Sub-Saharan Africa.[NIH News]
As director of Beth Israel Deaconess’s Center for Virology and Vaccine Research, Barouch is behind a new vaccine that could stop the disease [HIV] in its tracks. [Boston Magazine article]
